Skip to main content

Maternal adverse childhood experiences (ACEs) and DNA methylation of newborns in cord blood

Abstract

Background

Adverse childhood experiences (ACEs) increase the risk of poor health outcomes later in life. Psychosocial stressors may also have intergenerational health effects by which parental ACEs are associated with mental and physical health of children. Epigenetic programming may be one mechanism linking parental ACEs to child health. This study aimed to investigate epigenome-wide associations of maternal preconception ACEs with DNA methylation patterns of children. In the Center for the Health Assessment of Mothers and Children of Salinas study, cord blood DNA methylation was measured using the Illumina HumanMethylation450 BeadChip. Preconception ACEs, which occurred during the mothers’ childhoods, were collected using a standard ACE questionnaire including 10 ACE indicators. Maternal ACE exposures were defined in this study as (1) the total number of ACEs; (2) the total number of ACEs categorized as 0, 1–3, and > 4; and (3) individual ACEs. Associations of ACE exposures with differential methylated positions, regions, and CpG modules determined using weighted gene co-expression network analysis were evaluated adjusting for covariates.

Results

Data on maternal ACEs and cord blood DNA methylation were available for 196 mother/newborn pairs. One differential methylated position was associated with maternal experience of emotional abuse (cg05486260/FAM135B gene; q value < 0.05). Five differential methylated regions were significantly associated with the total number of ACEs, and 36 unique differential methylated regions were associated with individual ACEs (Šidák p value < 0.05). Fifteen CpG modules were significantly correlated with the total number of ACEs or individual ACEs, of which 8 remained significant in fully adjusted models (p value < 0.05). Significant modules were enriched for pathways related to neurological and immune development and function.

Conclusions

Maternal ACEs prior to conception were associated with cord blood DNA methylation of offspring at birth. Although there was limited overlap between differential methylated regions and CpGs in modules associated with ACE exposures, statistically significant regions and networks were related to genes involved in neurological and immune function. Findings may provide insights to pathways linking psychosocial stressors to health. Further research is needed to understand the relationship between changes in DNA methylation and child health.

Introduction

Adverse childhood experiences (ACEs) encompass a set of potentially traumatic events that occur during childhood, before age 18 years, and are associated with poor health outcomes during adolescence and adulthood [1]. Examples of ACEs include physical and emotional neglect, substance abuse, parental divorce, incarceration of family members, mental illness in the family, and physical, emotional, and sexual abuse. ACEs are a pervasive issue with around 60% of adults in the USA reporting experiencing at least one ACE before age 18, and around 22% reporting experiencing 3 or more ACEs [1, 2]. Of note, ACEs are more prevalent among children in racially and ethnically marginalized populations as well as those residing in low- and middle-income countries [2,3,4].

ACEs are a significant public health issue because they have negative impacts on mental and physical health, education, and job opportunities. During child development, they, along with other social determinants of health, contribute to toxic stress, which can cause neurodevelopmental disruption, epigenetic changes, and reprogramming of stress and immune regulatory systems that affect a child’s developmental trajectory and life course [5, 6]. Through these mechanisms, they have been associated with increased risk of many negative physical, psychological, and social outcomes during childhood, including asthma, headaches, obesity, attention-deficit/hyperactivity disorder, and earlier use of alcohol [7]. During adulthood, ACEs have been linked to an increased risk of cardiovascular disease, chronic obstructive pulmonary disease, dementia, suicide attempts, and injection drug use [6, 8, 9]. These associations can contribute to billions of dollars of economic and social costs each year; a 10% reduction in ACE prevalence in North America is estimated to result in an annual savings of 1 million disability-adjusted life years or $56 billion [10].

There is growing interest in how adverse events experienced by parents affect health outcomes in their offspring. Maternal preconception ACEs have been associated with increased risk of hypertensive disorders of pregnancy, preterm birth, and prenatal depressive symptoms. Maternal psychological challenges have also been shown to increase child behavioral dysregulation [11]. This evidence demonstrates that psychosocial stressors experienced early in the life of pregnant individuals can have downstream effects on the prenatal and postnatal time periods [12, 13]. The effect of maternal preconception ACEs on infant developmental outcomes can occur through biophysical and behavioral mechanisms related to increased prenatal health risks, pregnancy psychosocial risks, and postpartum psychosocial risks [14]. Children of mothers with a high number of ACEs were found to have increased risk for depressive symptoms, anxiety, aggression, hyperactivity, and temperament issues [15, 16]. The development of negative psychosocial outcomes among children of mothers with ACEs may be attributable to prenatal substance use, exacerbated stress and depression, emotional maladaptive behaviors, and biological programming, such as through epigenetic changes, during the prenatal and postnatal periods [5, 16, 17]. For example, a greater number of maternal ACEs has been associated with increased epigenetic age acceleration among offspring in the current cohort [18], as well as shorter telomere length throughout infancy in other studies, which contributed to higher risk for maladaptive externalizing behaviors at 18 months of age [19]. Studies in animal models have also supported inter- and transgenerational inheritance of trauma through non-genetic inheritance involving the germline [20]. Notably, in mouse models, behavioral alterations have been observed in the F2 generation following chronic stress exposure [21]. In a mechanistic study, trauma experienced by male mice-modified microRNAs of sperm, and injection of sperm microRNAs into fertilized wild-type oocytes conferred trauma-related behavioral changes to offspring [22], providing evidence that intergenerational effects of trauma are due in part to molecular mechanisms independent of parenting behaviors.

Changes in DNA methylation (DNAm) that occur during fetal development and throughout life and offspring inheritance of maternal epigenetic patterns may also confer vulnerability to many pathologic conditions [23]. Associations of cumulative lifetime maternal stress and maternal stress experienced during pregnancy with DNAm of offspring have been studied in epigenome-wide association studies (EWAS) [24, 25], including in a large meta-analysis of 12 cohorts [26]. EWAS of ACEs and DNAm in adulthood [27], as well as EWAS [28, 29] and candidate-gene approaches [30, 31] of maternal preconception ACE exposures and offspring DNAm support the hypothesis that ACEs affect differential DNAm of specific genes. However, these studies have focused on the number of ACEs rather than ACE categories and findings have been inconsistent across studies.

In the Center for the Health Assessment of Mothers and Children of Salinas (CHAMACOS) study, a longitudinal birth cohort from a predominantly Mexican immigrant farmworker population in California [32], we previously reported associations between maternal ACEs and children’s epigenetic age acceleration [18]. In the current study, we expand upon this research by performing an EWAS among CHAMACOS participants to assess the relationship between maternal preconception ACEs, analyzed as total number of ACEs and individual ACEs reported, and newborn cord blood DNAm patterns.

Results

Participant characteristics

From an initial cohort of 601 mother/newborn pairs, 372 had high-quality DNAm data. Mothers’ ACEs were collected using an adaptation of the ACE questionnaire [33] including 10 indicators, which was administrated approximately 18 years after the birth of the index child. A total of 203 mother/newborn pairs had data on DNAm and any ACE indicator; missingness was primarily due to loss to follow-up. Our analyses included 196 mother/newborn pairs with full data on maternal ACEs, cord blood DNAm, and other covariates (Additional file 1: Fig. S1). Characteristics of maternal/newborn pairs were similar for those included in analyses (Table 1) and the full sample with available DNAm data (Additional file 1: Table S1).

Table 1 Participant characteristics and adverse childhood experiences (ACEs) of mother/newborn pairs included in analyses

The mean ± standard deviation (SD) maternal age at delivery was 25.7 ± 4.8 years (Table 1). On average, mothers had a parity of 1.2 ± 1.1 births and had pre-pregnancy body mass index (BMI) of 27.2 ± 5.1. Forty percent of mothers (n = 80; 40.8%) had 6th grade or lower education, while 40.3% (n = 79) attained 7th–12th grade education and 18.9% (n = 37) graduated from high school. Eight mothers (4.1%) reported ever smoking while pregnant. Forty-three percent of mothers were married (n = 85; 43.4%) and 38.8% were living as married (n = 76) at the time of delivery, while 5.1% were separated or divorced (n = 10), and 12.8% were single and had never married (n = 25). The majority of mothers reported Mexico as their country of origin (n = 172; 87.8%), and having spent ≤ 1 (n = 34; 17.3%), 2–5 (n = 53; 27.0%), or 6–10 (n = 57; 29.1%) years in the USA. Slightly fewer than half of newborns were male (n = 94; 48.0%), and the mean gestational age was 39.1 ± 1.5 weeks.

Maternal adverse childhood experiences (ACEs)

Approximately half of mothers (n = 101; 51.5%) reported no ACEs, while 26.5% (n = 52) reported 1–3 ACEs, and 21.9% (n = 43) reported 4–10 ACEs (Table 1). The ACEs most frequently reported by mothers were physical abuse (n = 47; 24.0%), emotional neglect (n = 44; 22.4%), emotional abuse (n = 43; 21.9%), parental divorce (n = 42; 21.4%), and substance abuse in the household (n = 40; 20.4%). The report of any ACE increased the odds of every other ACE, with pairwise odds ratios ranging from 3.4 for domestic violence and physical neglect (95% confidence interval (CI): 1.1, 9.9) to 51.4 for emotional and physical abuse (95% CI: 19.5, 135.4) (Additional file 1: Fig. S2). The maximum variance inflation factor for the mutually adjusted model matrix including all ACEs was 3.30, indicating no major issues with collinearity (data not shown).

CpG-by-CpG epigenome-wide association study (EWAS) analyses

Associations with individual cytosine-phosphate-guanine (CpG) dinucleotides in cord blood were analyzed using three complementary approaches to defining maternal ACE exposures: (1) total number of ACEs modeled linearly; (2) total number of ACEs categorized as 0, 1–3, or 4–10, allowing for nonlinear effects; and (3) each of the 10 ACEs in a mutually adjusted model. Models were adjusted for a priori selected confounders or precision variables of newborn sex, gestational age, and cord blood estimated cell type proportions, and maternal parity, pre-pregnancy BMI, age at delivery, educational attainment, smoking during pregnancy, and marital status. Within each model, we adjusted for multiple comparisons (i.e., number of CpGs x number of exposure variables) by calculating q values using the false discovery rate (FDR) control approach of Storey and Tibshirani [34]. Differentially methylated positions (DMPs) were defined as CpGs with q values ≤ 0.05. CpG-by-CpG results from the EWAS are available at the study’s Open Science Framework (OSF) repository at https://osf.io/ync5t/.

We did not identify any DMPs associated with the total number of ACEs modeled linearly (Manhattan plot presented in Additional file 1: Fig. S3) or modeled categorically (Manhattan plots in Additional file 1: Fig. S4). When individual ACEs were included in a mutually adjusted model (Manhattan plots in Additional file 1: Fig. S5), we observed one DMP positively associated with emotional abuse (cg05486260; FAM135B) (q value < 0.05) (Table 2).

Table 2 Differentially methylated position (DMP; q value < 0.05) associated with maternal adverse childhood experiences (ACEs)

Genomic inflation was evaluated using Q–Q plots and the genomic inflation factor (λ) (Additional file 1: Figs. S6–S8). In the mutually adjusted model of individual ACEs, some degree of genomic inflation, i.e., observed p values systematically lower or more significant than the expected under the null hypothesis distribution, was observed for emotional neglect (λ = 1.65), substance abuse (λ = 1.54), and mental illness (λ = 1.40) (Additional file 1: Fig. S8). Deflation, perhaps corresponding to a lack of statistical power, was evident for emotional abuse (λ = 0.86), physical abuse (λ = 0.89), and parental divorce (λ = 0.67). Deflation was also present for 1–3 versus 0 ACEs in the categorical model of total ACEs (λ = 0.75), although deflation was less evident for 4–10 versus 0 ACEs (λ = 0.97) or 4–10 versus 1–3 ACEs (λ = 1.13) (Additional file 1: Fig. S7).

We looked up the DMP cg05486260 in the EWAS Catalog database [35]. This CpG has previously been associated with gestational age in fetal brain tissue [36] and with age in a longitudinal analysis of cord blood and blood collected in childhood and adolescence [37].

We also evaluated if results from two previous studies replicated in our analyses. Moore et al. investigated associations between the number of maternal ACEs and DNAm measured in blood collected from infants at age 3 months (N = 92) [29]. The top CpG located in each of 142 correlated methylated regions (p < 0.005) as well as 189 individual CpGs (p < 0.0005) were reported, of which 314 were included in our study. Among these CpGs, 129 were nominally significant (p value < 0.05) in at least one of our models (total number of ACEs: 14 CpGs; total number of ACEs categorical, 1–3 vs. 0: 8 CpGs; 4–10 vs. 0: 12 CpGs; 4–10 vs. 1–3: 15 CpGs; mutually adjusted, emotional abuse: 13 CpGs; physical abuse: 11 CpGs; sexual abuse: 11 CpGs; emotional neglect: 19 CpGs; physical neglect: 10 CpGs; domestic violence: 15 CpGs; substance abuse: 20 CpGs; mental illness: 23 CpGs; incarceration: 13 CpGs; divorce: 9 CpGs), although none remained significant after adjusting for multiple comparisons in our EWAS (Additional file 2: Table S1).

Kotsakis Ruehlmann et al. conducted a meta-analysis of maternal prenatal stressors in the Pregnancy and Childhood Epigenetics (PACE) consortium (p value < 2.4 × 10–7) [26]. Of the five DMPs associated with prenatal cumulative stress or individual stress domains in PACE, four were analyzed in our study. Only one DMP achieved nominal significance (p value < 0.05) in any of our EWAS (Additional file 2: Table S2). The site, cg14228885, annotated to APTX, had higher methylation among mothers who reported experiencing conflict with family and friends during pregnancy in eight cohorts included in the PACE meta-analysis, and had higher methylation among mothers who reported substance abuse in the household in our study (p = 0.005).

Regional epigenome-wide association analyses

Differentially methylated regions (DMRs) in cord blood were identified using comb-p with a Šidák multiple testing correction [38], and significant DMRs were defined as regions with a Šidák p value ≤ 0.05. DMRs were associated with the total number of ACEs modeled linearly (4 DMRs), the total number of ACEs modeled categorically (1 DMR for 4–10 ACEs vs. 0 ACEs), and individual ACEs in a mutually adjusted model (3 DMRs for emotional abuse, 6 DMRs for sexual abuse, 2 DMRs for emotional neglect, 9 DMRs for physical neglect, 4 DMRs for domestic violence, 3 DMRs for substance abuse, 5 DMRs for mental illness, 3 DMRs for incarceration, and 3 DMRs for parental divorce) (Šidák p value < 0.05) (Table 3).

Table 3 Differentially methylated regions (DMRs) associated with maternal adverse childhood experiences (ACEs)

There was minimal overlap between DMRs. The total number of ACEs modeled linearly and emotional neglect in the mutually adjusted model were associated with lower methylation of overlapping DMRs on chromosome 6 (VWA7), sexual abuse and domestic violence were associated with overlapping DMRs on chromosome 4 (STX18-AS1) with opposite directions of association, and physical neglect and mental illness were associated with a DMR on chromosome 11 (intergenic; chr11: 67,383,425–67,383,863) with opposite directions of association.

Weighted correlation network analysis

Weighted correlation network analysis, or weighted gene co‐expression network analysis (WGCNA) [39], performed on M-values identified 29 modules, ranging in size from 30 CpGs (the minimum module size set in the call to the blockwiseModules function) to 109,576 CpGs. One module, which was composed primarily of probes located on the sex chromosomes, was excluded from further analyses. Information required to reconstruct identified WGCNA modules is available at the OSF repository at https://osf.io/ync5t/. Module eigengenes of the 28 remaining modules exhibited strong representativeness, accounting for 41.0–74.0% of the total variation among probes belonging to each module (Additional file 1: Table S2). Median absolute Pearson correlations between included probes and module eigengenes raged from 0.63–0.91. Bivariate associations between module eigengenes (MEs) and the total number of ACEs, individual ACEs, and covariates were evaluated using Pearson correlations (Fig. 1 and Additional file 1: Table S3 and Fig. S9). Modules significantly correlated with ACE exposures (p < 0.05) were further analyzed using adjusted models (Figs. 2 and 3 and Additional file 1: Table S3). Pathway enrichment analysis was performed for significant modules using the Kyoto Encyclopedia of Genes and Genomes (KEGG) [40] and Gene Ontology (GO) [41, 42] databases (Table 4 and Additional file 3: Tables S1 and S2).

Fig. 1
figure 1

Correlations of module eigengenes (MEs) with maternal adverse childhood experience (ACEs). Pearson correlations with weighted correlation analysis (WGCNA) MEs were calculated for individual maternal ACEs, total maternal ACEs, and covariates. Pearson correlations (p values; q values) are shown in cells. Only MEs significantly correlated with the total number of ACEs or individual ACEs (p < 0.05) are shown

Fig. 2
figure 2

Associations of module eigengenes (MEs) with the number of maternal adverse childhood experiences (ACEs). MEs were derived from weighted correlation analysis (WGCNA). The total number of ACEs was modeled linearly or as a categorical variable of 0, 1–3, or 4–10. Bivariate associations were evaluated using Pearson correlations. Adjusted associations were evaluated using models including newborn sex, gestational age, and cord blood estimated cell type proportions, and maternal parity, pre-pregnancy BMI, age at delivery, educational attainment, smoking during pregnancy, and marital status. Where applicable, summaries of associated biological pathways derived from enrichment analyses are displayed parenthetically next to module names

Fig. 3
figure 3

Associations of module eigengenes (MEs) with individual maternal adverse childhood experiences (ACEs). MEs were derived from weighted correlation analysis (WGCNA). Bivariate associations were evaluated using Pearson correlations. Adjusted associations were evaluated using models including newborn sex, gestational age, and cord blood estimated cell type proportions, and maternal parity, pre-pregnancy BMI, age at delivery, educational attainment, smoking during pregnancy, and marital status. Mutually adjusted associations were evaluated using adjusted models including all covariates and ACEs. Where applicable, summaries of associated biological pathways derived from enrichment analyses are displayed parenthetically next to module names

Table 4 Pathways enriched for ACE-associated modules

Fifteen MEs exhibited significant correlations (p < 0.05) with the total number of ACEs or individual ACEs (Fig. 1 and Additional file 1: Table S3). Examining relationships between covariates and ACE-associated MEs, we found the greatest correlations between newborn sex and the Blue, Pink, SaddleBrown, and RoyalBlue modules (|ρ| range: 0.18–0.22; p < 0.05) (Fig. 1). At least one ACE-associated ME was also significantly but weakly correlated with gestational age, maternal age at delivery, % granulocytes, and % nucleated red blood cells (|ρ| range: 0.15–0.17; p < 0.05). MEs not associated with ACEs were significantly correlated with newborn sex, maternal smoking and age at delivery, and % CD4 + T cells (|ρ| range: 0.14–0.22; p < 0.05) (Additional file 1: Fig. S9). This suggests that modules represent biologically meaningful DNAm networks, but also that maternal ACE exposures are associated with DNAm networks unique from other biological or sociodemographic factors.

The total number of ACEs modeled linearly was significantly correlated with the MidnightBlue (enriched for cell-mediated immune response; \(\rho \hspace{0.17em}\)= 0.15; p = 0.039), Sienna4 (\(\rho \hspace{0.17em}\)= − 0.20; p = 0.006), and Yellow3 (\(\rho \hspace{0.17em}\)= − 0.22; p = 0.002) MEs (Fig. 1 and Additional file 1: Table S3). After adjustment for covariates, associations with the total number of ACEs remained similar (Fig. 2 and Additional file 1: Table S3). In bivariate and covariate adjusted analyses of the total number of ACEs modeled categorically, 4–10 ACEs versus 0 ACEs was significantly associated with the MidnightBlue, Sienna4, and Yellow3 MEs (p < 0.05), consistent with modeling the total number of ACEs linearly. However, estimates of FDRs of linear and categorical associations of total number of ACEs and MEs (q values) were > 0.05 (Fig. 1 and Additional file 1: Table S3 and Fig. S9).

In bivariate analyses, mental illness was significantly associated with the most MEs (p < 0.05) (8 MEs: Pink, enriched for cellular metabolic and biosynthetic processes; RoyalBlue; Magenta, enriched for immune and inflammatory response; MidnightBlue, enriched for cell-mediated immune response; Turquoise, enriched for ion transport and cell signaling; Sienna4; DarkOliveGreen; and Yellow3) (Fig. 1 and Additional file 1: Table S3). Significant bivariate associations were also observed for emotional abuse (4 MEs: Blue, enriched for neurodegenerative disease/cellular anatomy and metabolism; SkyBlue4; MidnightBlue; and Brown, enriched for ErbB and oxytocin signaling/cell projection), sexual abuse (3 MEs: LightCyan, Sienna4, and Yellow3), divorce (3 MEs: SkyBlue4; Salmon, enriched for immune and inflammatory response/cell death and cancer; and MidnightBlue), physical neglect (3 MEs: Sienna4, DarkOliveGreen, and Yellow3), physical abuse (2 MEs: SkyBlue4 and MidnightBlue), emotional neglect (2 MEs: SaddleBrown, enriched for embryonic development; and Yellow3), domestic violence (2 MEs: Ivory, enriched for cell adhesion and ion binding; and Yellow3), and substance abuse (1 ME: Yellow3). Overall, associations were robust after adjustment for covariates (Fig. 3 and Additional file 1: Table S3). In mutually adjusted models including all ACEs and covariates, the direction of associations was consistent with bivariate analyses, but most associations were nullified. Only associations of mental illness with the RoyalBlue and MidnightBlue MEs, sexual abuse with the LightCyan1 and Sienna4 MEs, divorce with the Salmon ME, and emotional neglect with the SaddleBrown ME remained significant (p < 0.05). As with analyses of total number of ACEs, estimated q values of bivariate associations between individual ACEs and MEs were > 0.05 (Fig. 1 and Additional file 1: Table S3 and Fig. S9), suggesting caution in interpreting findings.

There was minimal overlap between DMPs, DMRs, and CpGs included in modules associated with ACE exposures. The Blue module (enriched for neurodegenerative disease/cellular anatomy and metabolism) was associated with maternal experiences of emotional abuse and included CpGs in DMRs associated with maternal experiences of sexual abuse, physical neglect, and domestic violence. The Brown module (enriched for ErbB and oxytocin signaling/cell projection) was associated with maternal experience of emotional abuse and included CpGs in DMRs associated with sexual abuse, emotional neglect, and physical neglect. In addition, the Turquoise module (enriched for ion transport and cell signaling), associated with maternal experience of mental illness in the household, included the DMP associated with emotional-abuse (cg0548620, FAM135B), as well as CpGs in DMRs associated with physical neglect and domestic violence.

Discussion

The aim of this study was to examine associations between maternal ACEs and offspring DNAm profiles at birth, including differentially methylated CpGs (DMPs), regions (DMRs), and CpG networks, among mother/newborn pairs who were primarily of Mexican origin and low socioeconomic status [32]. While previous studies have found that maternal adverse experiences are associated with differential methylation of candidate genes among children [30, 31] and accelerated epigenetic aging in children from the current cohort [18], research on the relationship between maternal ACEs and differential methylation on an epigenome-wide level in offspring is nascent. This research may help to elucidate potential biological pathways through which a mother’s adverse physical and psychological experiences impact their child’s health, which can assist in the development of more targeted prevention and therapies. To our knowledge, this is one of the first studies to use cord blood samples to examine the impact of maternal ACEs, including both the number of ACEs reported and individual ACEs, on offspring’s epigenome at large. Using cord blood samples allows us to better understand the impact of maternal adversity on DNAm during fetal development, a time of epigenetic reprogramming with potential downstream consequences for health later in life [43].

We found that emotional abuse experienced by mothers was significantly associated with one DMP in cord blood, cg05486260, annotated to the FAM135B gene. In agreement with a study of maternal ACEs and DNAm measured in infant blood and buccal epithelial cells [29] and a study of cord blood [28], we did not find significant associations between the number of maternal ACEs and DMPs after adjustment for multiple comparisons. A recent EWAS of total paternal ACEs and blood collected from infants also found few DMPs, with 8 DMPs in meeting the criteria of FDR < 0.2 and a biological threshold |Δβ < 0.03|, of which one was significant at FDR < 0.05 [44]. A PACE consortium meta-analysis found 5 DMPs associated with maternal stressors during pregnancy (p < 2.4 × 10–7) [26], although in our study only one of these CpGs was associated with substance abused in the household at a nominal p value < 0.05. Although our findings contribute to a growing body of research linking parental stressful or adverse experiences to epigenetic modifications in children, replication of findings across multiple cohorts is necessary to fully establish and understand this relationship. In our look-up approach, we found limited consistency with results from previous studies [26, 29], which might be due to differences in the populations studied and the specificity, intensity, chronicity, and timing of the exposure.

We found a greater number of associations with DMRs, including significant associations with the total number of ACEs and with emotional abuse, sexual abuse, emotional neglect, physical neglect, domestic violence, substance abuse, mental illness, incarceration, and parent divorce, although there was minimal overlap between the DMRs identified through different analytic models. Previous research has also shown weak associations between total maternal ACEs and correlated methylated regions of infant blood and buccal cells [29]. We also evaluated associations between modules of CpGs, defined using WGCNA, and maternal ACE exposures. WGCNA defines modules of co-methylated CpGs that may have related biological function and therefore, may be advantageous to understanding relationships between DNAm and complex exposures or phenotypes. We found significant associations between the total number of maternal ACEs or individual ACEs and 15 module eigengenes (MEs), which were largely robust after adjusting for covariates (p < 0.05). However, q values, i.e., estimates of FDRs of accepting any bivariate associations of ACE exposures and MEs, exceeded 0.05, suggesting caution in interpreting findings.

Downstream effects of adversity experienced by parents in early life include depression, anxiety, post-traumatic stress disorder (PTSD), developmental delay, and behavioral problems in their offspring [6, 45]. Moreover, mouse models have demonstrated that maternal trauma during pregnancy is associated with differential expression in offspring brains of genes associated with depression in humans [46]. In the current analysis, we found that maternal report of substance abuse in her household during childhood was associated with offspring regional DNAm of PNPO, a protein coding gene involved in the biosynthesis of vitamin B6, which is a co-factor for neurotransmitter synthesis. PNPO deficiency has been linked to neurodevelopmental impairment and epilepsy [47]. We also found that maternal childhood experience of sexual abuse was associated with offspring regional methylation of CACNA1C. The CACNA1C gene encodes for a transmembrane calcium channel subunit. Genetic variation of CACNA1C has been associated with neurodevelopmental delays and disorders including schizophrenia, autism, and bipolar disorder [48,49,50,51], and DNAm methylation of CACNA1C has been associated with bipolar disorder [52], suggesting that maternal ACEs may put children at greater risk for these disorders. Moreover, a cross-sectional study of young adults found a gene × environment interaction in the association of CACNA1C polymorphisms with bipolar disorder, with variant carriers exposed to childhood trauma at greater risk [53]. In addition, we found that maternal report of mental illness in the household was significantly associated with the Turquoise co-methylation module, enriched for the neuroactive ligand-receptor interaction and calcium signaling pathways, and that domestic violence in the household was associated with the Ivory co-methylation module, enriched for calcium ion binding. These associations suggest a relationship between preconception maternal ACEs and neurodevelopment and neuronal function in children [54].

Dysregulation of the immune system may be another pathway through which adverse experiences impact health [5, 55, 56]. Stress and adversity in early life has been associated with increased inflammatory markers and susceptibility to infectious diseases. We identified a DMR annotated to the HLA-DPB1 gene, a member of the major histocompatibility complex (MHC). DNAm of HLA-DPB1 has previously been associated with PTSD [57, 58]. In our analyses of co-methylation modules, we found several MEs associated with maternal ACE exposures to be enriched for pathways related to immune function. In particular, the Salmon module, associated with parental divorce, and the Magenta module, associated with mental illness in the household, were enriched for immune and inflammatory response pathways. Future studies on ACEs should consider testing co-methylation modules in addition to epigenome-wide CpG testing, which might allow for potential replication of biological pathways affected.

Strengths of this study include use of a validated, standardized measures of maternal ACEs, application of an epigenome-wide approach, and multiple modeling strategies. Our study was also strengthened by the use of cord blood samples which allows us to rule out the possibility that associations are due to similar social and environmental exposures between mothers and children after birth, although we cannot rule out possibility of shared exposures while children were in utero. We also employed multiple analytical techniques which allowed us to investigate associations between ACEs and individual methylation loci, differentially methylated regions, and networks of co-methylated CpGs, in addition to analyzing the total number of ACEs linearly, categorized number of ACEs for nonlinearity, and analyzing associations with individual ACEs mutually adjusting for all other ACEs. Although use of multiple models may increase the risk of type-one errors, we adjusted for multiple comparisons within each model and evaluated statistical significance using a false discovery rate approach (i.e., q value ≤ 0.05). However, we chose not to correct for multiple comparisons between models as hypotheses were related.

A limitation of this study is that 176 of the 372 mother/newborn pairs with cord blood DNAm from the original cohort were excluded due to missing data on maternal ACEs. Maternal ACEs were collected at the child’s 18-year follow-up visit, and, therefore, loss to follow-up was a major factor in the missingness of these data. However, characteristics of mother/newborn pairs included in analyses were similar to all pairs with DNAm data, and we do not expect bias due to loss to follow-up. Low response rates to questions about ACEs are also common [59] and may reflect participant hesitation to disclose traumatic or stigmatizing events to researchers. However, in CHAMACOS, mothers were encouraged to respond to ACE questions privately and independently if possible. Five percent of women from the original cohort declined to answer any ACEs questions, and an additional 4% declined to answer between 1 and 9 specific ACEs. Another limitation of this study is there may have been some recall inaccuracy and bias of ACEs exposure, given mothers completed this questionnaire at the 18-year follow-up visit, although retrospective report by adults of serious adverse experiences during childhood is expected to be valid [60].

Our small sample size decreased our power to detect associations with small effect sizes, particularly in CpG-by-CpG analyses, although our sample size was larger than that in previous studies of maternal ACEs and offspring DNAm of candidate genes [30, 31]. It should be noted, however, that a previous EWAS of maternal ACEs and cord blood DNAm in ARIES had a larger sample size (N = 896) [28] while a study of maternal ACEs and correlated methylated regions and infant DNAm in APrON had a smaller sample size (N = 92 and N = 124 for blood and buccal epithelial cells, respectively) [29]. We chose to test for DMRs using comb-p, which has greater power to detect DMRs with small effect sizes compared to alternate regional approaches [61]. However, it should be noted that comb-p may also have a greater Type I error rate [62], and therefore, our findings should be interpreted as candidate regions that may be investigated in larger studies. Due to the small sample size, we were also unable to test for effect modification, such as differential effects by newborn sex, which may influence prenatal programming in response to maternal stress and adverse experiences [28, 63, 64]. In addition, we adjusted models for potential confounders and precision variables selected a priori, including newborn sex and gestational age, cord blood estimated cell type proportions, and maternal pre-pregnancy BMI, age at delivery, parity, educational attainment, marital status, and smoking during pregnancy. These covariates have well-established associations with cord blood DNAm [65,66,67,68,69,70,71,72,73,74]. Although these some of these variables follow the experience of preconception ACEs and may be involved in mediating associations between maternal ACEs and offspring DNAm, our findings represent the direct effects of ACEs not acting through those pathways.

Future research should examine the impact of maternal ACEs on children’s DNAm profiles at different points throughout the life course (e.g., adolescence) to evaluate persistence and their role in the sequelae of health outcomes related to ACEs. While our study demonstrates that changes in children’s DNAm possibly reflect maternal adverse experiences prior to conception and birth, prospective, longitudinal cohort studies with repeated measurements may provide opportunities to study how DNAm changes in response to parental ACEs throughout an individual’s life into adulthood. Studies of the impact of maternal ACEs on offspring health or biomarkers in childhood and adolescence must also consider the contribution of the postnatal environment, which may play an important role as a mechanistic pathway or mediator beyond prenatal biological factors. Specifically, maternal anxiety, depression and parenting behaviors have been identified as mediators linking maternal ACEs with children’s internalizing and externalizing symptoms [75,76,77,78]. In addition, children’s own direct experience of ACEs must be considered. Future studies should also explore the effects of maternal ACEs on maternal DNAm during pregnancy and at delivery, and to what extent DMPs and DMRs serve as mediators between maternal ACEs and risk of diseases in offspring. These types of studies can help distinguish between environmental and biological pathways between maternal ACEs and childhood health, a key step in developing effective interventions. A recent systematic review [79] also highlighted the potential to investigate the impact of psychosocial interventions on changes in offspring DNAm, which may persist into adulthood [80]. This is a promising strategy for establishing DNAm as a mechanism or biomarker involved in pediatric health, as well as in important method for evaluating the effectiveness of preventive interventions. Finally, because replication of results across cohorts and studies remains a challenge due to small sample sizes and the need to adjust for multiple comparisons [27, 79], including questions on parental and child ACEs in large epigenomic databases may help researchers to conduct larger studies.

Conclusions

In summary, this study provides further evidence that mothers’ preconception adverse experiences may impact their child’s epigenome at birth. Both gene annotations of DMRs and enrichment analysis of ACE-associated co-methylated modules suggest changes in DNAm related to neurological and immune development and function, pathways previously implicated in response to stressful and adverse experiences. However, larger studies with more diverse populations are needed to fully understand the impact of maternal ACEs on epigenetic markers in children. In addition, further research is needed to investigate how changes in offspring DNAm at birth related to maternal ACEs may affect health later in life.

Methods

Study population

From October 1999 through October 2000, 601 pregnant women with \(\le\) 20 weeks gestation were recruited into the CHAMACOS study from a predominantly farmworker population of Mexican origin in California’s Salinas Valley [32]. Of these, 527 enrollees had a liveborn singleton delivery in 2000–2001. Enrollees were required to be either English- or Spanish-speaking, eligible for MediCal, planning to deliver at the county hospital, and attending prenatal care visits at one of six local clinics, primarily serving farmworker families. Cord blood samples were collected from 403 newborns for epigenomic analysis. Maternal and child characteristics were retrieved from medical records abstracted by a registered nurse and from interviews conducted by bilingual bicultural well-trained interviewers during the 1st and 2nd trimesters of pregnancy, shortly after delivery, and in regular follow-up interviews conducted most recently when the child was 18 years old. Mothers provided written consent for all study activities. Child written consent was obtained at the 18-year visit. Study activities were approved by the University of California, Berkeley Committee for the Protection of Human Subjects.

Maternal characteristics

Maternal characteristics included maternal age at delivery, pre-pregnancy BMI, whether the mother smoked at any time during pregnancy, marital status at first interview (married, living as married, separated, divorced, single), educational attainment (≤ 6th grade, 7–12th grade, ≥ 12th grade), and maternal parity.

Maternal adverse childhood experiences (ACEs)

Data collection of mothers’ ACEs has previously been described [18]. Of the 527 mothers followed to delivery, N = 319 (61%) participated in the 18-year follow-up interviews during which data on ACEs were collected using an adaptation of the ACEs questionnaire [33] administered in English or translated to Spanish. The interview was administered primarily aloud due to limited literacy among participants, with a study interviewer reading questions and response options from a computerized questionnaire and keying in the participant’s responses. Participants were encouraged to respond to the ACEs questions privately and independently if possible, though most chose to answer aloud. The questionnaire included 10 self-reported indicators of emotional, physical, or sexual abuse; emotional or physical neglect; substance abuse; incarceration; mental illness or domestic violence in the home; or parental divorce. Participants could decline to respond to one or more ACEs. Partial data on ACEs, i.e., response to one at least one individual ACE, were available for 303 mothers, and complete data used in the current analyses, i.e., responses to all 10 ACEs, were available for 289 mothers. ACEs were categorized as reported (1) or not reported (0).

Child characteristics at birth

Where possible, gestational age from medical records was calculated based on the self-reported last menstrual period of mothers. In cases where this information was missing or resulted in implausible estimates, ultrasound records were used to estimate gestational age at a weekly resolution. Data on the sex of the children were obtained from physical exams.

Child DNA methylation data

Cord blood specimens were collected at the time of delivery. DNA was extracted from banked non-heparinized umbilical cord using QIAamp DNA Blood Maxi Kits (Qiagen, Valencia, CA) following a previously described modified version of the manufacturer’s protocol [81]. Aliquots of 1 µg DNA extract were bisulfite converted using Zymo Bisulfite Conversion Kits (Zymo Research, Orange, CA), followed by whole-genome amplification, enzymatic fragmentation, and purification. DNAm was measured using Illumina Infinium HumanMethylation450 BeadChips (Illumina, San Diego, CA) according to the manufacturer’s protocol [82].

During DNAm data collection, repeats and randomization of samples across chips and plates were used to reduce the chance for artifactual confounding [74]. Quality control of DNAm data excluded samples with poor data quality, i.e., poor median methylated and unmethylated signal levels and with 1% of probes fluorescing below the limit of detection (n = 0); mismatch between recorded sex and sex estimated from DNAm data (n = 8), and replicate samples (n = 1). Functional normalization [83] was performed using the R package minfi (v1.36.0) [84] and normalizing of signal levels of type I and type II probes performed using the package ENmix (v1.26.10) [85]. The ComBat [86] method provided in the sva package (v3.38.0) [87] was used to remove batch effects associated with the bisulfite conversion step. Proportions of seven cell types (CD8 + T cells, CD4 + T cells, natural killer cells, B cells, monocytes, granulocytes, and nucleated red blood cells) were estimated from cord blood methylation profiles, using the method of Teschendorff et al. as provided in the package EpiDISH (v2.6.1) [88].

Statistical analysis

Epigenome-wide association analysis (EWAS), differentially methylated positions (DMPs). A total of 372 samples were retained with high-quality DNAm data, of which 196 with complete paired data on maternal ACEs and covariates were used for EWAS analyses. We performed three complementary EWAS that differed in the definition of maternal ACE exposures: (1) we applied the simplifying assumption that exposure to additional types of adverse experience has homogeneous effects on DNAm, treating the total number of ACEs as a continuous variable modeled linearly; (2) we regarded each additional type of adverse experience as homogenous and categorized the total number of ACEs as 0, 1–3, or 4–10 ACEs, allowing for nonlinear effects; and (3) we regarded each of the 10 indicators for different ACEs as distinct exposures, fitting coefficients for each in a mutually adjusted model. For each exposure definition, we fit linear models on the logit scale (M-values) with empirical Bayes adjustment of standard error terms using the package limma (v3.46.0) [89]. In addition to the exposure terms, models included the following covariates selected a priori based on previously reported associations with cord blood DNAm [65,66,67,68,69,70,71,72,73,74]: newborn sex, gestational age, and estimated nucleated cell-type composition, and maternal parity, pre-pregnancy BMI, age at delivery, educational attainment (6th grade or lower, 7–12th grade, or high school graduate), smoking during pregnancy (ever or never), and marital status at time of birth (married, living as married, separated, divorced, or single having never married). For each CpG, we extracted p values, coefficients, and standard errors associated with ACE exposure terms.

While regressing on the logit scale has appealing statistical properties for proportional outcomes [90], the fitted coefficients of a model on this scale describe methylation odds ratios, whereas it is often of interest to know the expected difference in percent methylation associated with an exposure. To this end, we retrieved plug-in estimates of predicted baseline methylation levels by defining a ‘reference individual’ as a child having the mean value of all numeric covariates and the modal value of categorical covariates (sex: female; gestational age: 273.36 days; cell type composition: 18.94% CD4 + T cells, 9.12% CD8 + T cells, 0.73% natural killer cells, 18.33% B Cells, 10.92% monocytes, 40.63% granulocytes, 1.33% nucleated red blood cells; maternal parity: 1.19 births; maternal pre-pregnancy BMI: 27.20; maternal age at delivery: 25.73 years; maternal educational attainment: 6th grade or lower; maternal smoking during pregnancy: no; maternal marital status: married), then contrasted predicted methylation levels for reference individuals with and without the exposure of interest. Confidence intervals for predicted differences in methylation were constructed by Monte Carlo simulating differences in predicted values between exposed and unexposed reference individuals 3000 times as follows:

$$\delta =\frac{1}{1+{e}^{-M\left({\varvec{\theta}},\boldsymbol{ }{{\varvec{X}}}_{1}\right)}}-\frac{1}{1+{e}^{-M\left({\varvec{\theta}},\boldsymbol{ }{{\varvec{X}}}_{0}\right)}}$$
$$M\left({\varvec{\theta}},{\varvec{X}}1\right)=\boldsymbol{\alpha }{\varvec{\theta}}+{\varvec{\beta}}{{\varvec{X}}}_{1}$$
$$M\left({\varvec{\theta}}, {{\varvec{X}}}_{0}\right)=\boldsymbol{\alpha }{\varvec{\theta}}+{\varvec{\beta}}{{\varvec{X}}}_{0}$$
$$\left\{\boldsymbol{\alpha },{\varvec{\beta}}\right\} \sim Multivariate\,normal\left(\left\{\widehat{\boldsymbol{\alpha }},\widehat{{\varvec{\beta}}}\right\}, \widehat{{\varvec{\Sigma}}}\right)$$

where \(\delta\) denotes the difference in methylation associated with exposure matrix \({{\varvec{X}}}_{1}\) in contrast to reference matrix \({{\varvec{X}}}_{0}\), \({\varvec{\theta}}\) is a matrix of covariates fixed to their average/modal values, \(\boldsymbol{\alpha }\) is a vector of randomly generated coefficients associated with covariates \({\varvec{\theta}}\), \({\varvec{\beta}}\) is a vector of randomly generated coefficients associated with exposures of interest, \(\widehat{\boldsymbol{\alpha }}\) and \(\widehat{{\varvec{\beta}}}\) are the fitted point estimates of the coefficients, and \(\widehat{{\varvec{\Sigma}}}\) is their variance–covariance matrix.

We assessed the distribution of p values from each CpG-by-CpG EWAS via quantile–quantile plots and calculated genomic inflation factors (\(\lambda\)) for each exposure in each model. We adjusted for multiple comparisons, calculating q values using the FDR control approach of Storey and Tibshirani [34], as implemented in the R package q value (v2.22.0), noting any CpGs as differentially methylated for which a q value ≤ 0.05 was returned. Adjustment for multiple comparisons was performed separately for each specification of ACE exposures (i.e., three sets of multiple comparisons adjustments): total number of ACEs as a continuous variable, total number of ACEs as a categorical variable, and individual ACEs.

We conducted a look-up of the one DMP using the EWAS Catalog [35]. We also compared our EWAS results to findings reported by two recent studies. In the first study, associations between the number of maternal ACEs and infant DNAm measured in blood (N = 92) were analyzed using correlated methylated regions and individual CpGs not included in the regions [29]. The top CpG located in each 320 regions (p < 0.005) and 189 individual CpGs (p < 0.0005) were reported, none of which remained significant after an FDR correction. Although this study also investigated associations with infant DNAm measured in buccal epithelial cells, we limited our look-up to results from blood for greater similarity in tissue types. In the second study, associations of maternal stressful life events experienced during pregnancy and offspring DNAm were studied in a meta-analysis of 12 cohorts (N = 5496) conducted by the PACE consortium [26]. Prenatal stressors were analyzed as the cohort-specific proportion of stressors reported or five domains of stressors harmonized across cohorts, and five DMPs were identified (p < 2.4 × 10–7), four of which were included in our study. To assess if CpGs associated with maternal ACEs or prenatal stress were also associated with ACEs in our study, we conducted a look-up of reported CpGs in our EWAS results. Replication of was determined by a nominal p value < 0.05.

Differentially methylated region (DMR) analysis. We searched for DMRs using a modified comb-p method as provided in Enmix (v1.26.10) [91], with maximum distance between base pairs within a DMR set to 1000 and a seed value (FDR significance threshold for initial selection of DMR regions) of 10–3 [38]. We defined significant DMRs as those with ≥ 3 CpGs and a Šidák-adjusted p value ≤ 0.05.

Weighted gene co-expression network analysis (WGCNA). We utilized the R package WGCNA (v1.70.3) [39] to perform weighted correlation network analysis, or weighted gene co‐expression network analysis (WGCNA), of methylation M-values across the epigenome. WGCNA provides a suite of tools for tasks including the identification of non-contiguous network modules of covarying signal loci, identification of central loci in the network (e.g., clusters of covarying CpG probes situated on different chromosomes), and extraction of summary statistics of module-wide signals such as the eigengene [92] (a measure of distance along the module’s principal axis of variation) which can then be related to exposures or traits of interest. We used the blockwiseModules function to feasibly calculate unsigned Topological Overlap Matrices for our high dimensional methylation data, then identify covarying modules via hierarchical clustering and dynamic tree cutting algorithms [93] and calculated module eigengenes (MEs) for each subject. One module was composed primarily of probes located on the sex chromosomes and was excluded from further analyses.

To identify modules associated with maternal ACEs, we calculated Pearson correlations between MEs and total ACEs, as well as individual ACEs separately. Analogous to our approach for FDR control in our EWAS analysis, we estimated q values separately for each specification of ACE exposures: total number of ACEs as a continuous variable, total number of ACEs as a categorical variable, and individual ACEs. For linear and categorical specifications of total ACEs (28 and 56 tests, respectively), we used the Benjamini–Hochberg FDR estimation, which has higher specificity at low sample sizes but reduced power [94, 95]. For individual ACEs (280 tests), we used the estimation Strimmer method for estimating q values [94, 96]. For ME-ACE relationships exhibiting a correlation p value ≤ 0.05, we assessed the robustness of the association by constructing linear regressions with the ME as outcome, ACE measure as main exposure, and adjusting for newborn sex, gestational age, and estimated nucleated cell-type composition, and maternal parity, pre-pregnancy BMI, age at delivery, educational attainment, smoking during pregnancy, and marital status. For individual ACEs, we additionally assessed the significance of their association with MEs in a mutually adjusted model in which all ACEs were included simultaneously along with the covariates listed above. FDRs were estimated only for bivariate associations to provide an indication of the level of confidence of the probability that associations in our exploratory analyses did not arise by change under multiple testing. FDR estimates were not calculated for adjusted modules, since these estimates had already been subjected to a selection process informed by the same data.

We performed KEGG [40] and GO [41, 42] pathway enrichment analyses for modules significantly associated with ACE exposures after adjustment for other covariates using the gometh function in the missMethyl package (v1.26.1). This function accepts a vector of CpGs included in each module and a vector of all CpGs used in WGCNA. Enrichment p values were adjusted for prior gene selection probabilities inherent to the Illumina array [97, 98], and pathways with intra-module FDR ≤ 0.05 were considered to be enriched.

Availability of data and materials

The datasets supporting the conclusions of this article are not publicly available; consent for public release of epigenetic data was not obtained from all participants. However, full CpG-by-CpG results from the EWAS and information required to reconstruct identified WGCNA modules are available at the study’s Open Science Framework (OSF) repository (https://osf.io/ync5t/). Additional output to generate figures and tables is available from the corresponding author with the appropriate permission from the CHAMACOS team and investigators upon reasonable request and Institutional Review Board approval.

Abbreviations

ACES:

Adverse childhood experiences

DNAm:

DNA methylation

EWAS:

Epigenome-wide association study

CHAMACOS:

Center for the Health Assessment of Mothers and Children of Salinas

SD:

Standard deviation

BMI:

Body mass index

CI:

Confidence interval

CpG:

Cytosine-phosphate-guanine dinucleotide

FDR:

False discovery rate

DMP:

Differentially methylated position

OSF:

Open science framework

PACE:

Pregnancy and Childhood Epigenetics Consortium

DMR:

Differentially methylated region

WGCNA:

Weighted gene co-expression network analysis

ME:

Module eigengene

KEGG:

Kyoto Encyclopedia of Genes and Genomes

GO:

Gene ontology

PTSD:

Post-traumatic stress disorder

MHC:

Major histocompatibility complex

References

  1. CDC National Center for Injury Prevention and Control, Division of Violence Prevention. Fast Facts: Preventing Adverse Childhood Experiences [Internet]. 2023. Available from: https://www.cdc.gov/violenceprevention/aces/fastfact.html

  2. Giano Z, Wheeler DL, Hubach RD. The frequencies and disparities of adverse childhood experiences in the U.S. BMC Public Health. 2020;20:1327.

    Article  PubMed  PubMed Central  Google Scholar 

  3. Kidman R, Piccolo LR, Kohler H-P. Adverse childhood experiences: prevalence and association with adolescent health in Malawi. Am J Prev Med. 2020;58:285–93.

    Article  PubMed  Google Scholar 

  4. LaBrenz CA, O’Gara JL, Panisch LS, Baiden P, Larkin H. Adverse childhood experiences and mental and physical health disparities: the moderating effect of race and implications for social work. Soc Work Health Care. 2020;59:588–614.

    Article  PubMed  Google Scholar 

  5. Soares S, Rocha V, Kelly-Irving M, Stringhini S, Fraga S. Adverse childhood events and health biomarkers: a systematic review. Front Public Health. 2021;9:649825.

    Article  PubMed  PubMed Central  Google Scholar 

  6. Nelson CA, Scott RD, Bhutta ZA, Harris NB, Danese A, Samara M. Adversity in childhood is linked to mental and physical health throughout life. BMJ. 2020;371:m3048.

    Article  PubMed  PubMed Central  Google Scholar 

  7. Hughes K, Bellis MA, Hardcastle KA, Sethi D, Butchart A, Mikton C, et al. The effect of multiple adverse childhood experiences on health: a systematic review and meta-analysis. Lancet Public Health. 2017;2:e356–66.

    Article  PubMed  Google Scholar 

  8. Petruccelli K, Davis J, Berman T. Adverse childhood experiences and associated health outcomes: a systematic review and meta-analysis. Child Abuse Negl. 2019;97:104127.

    Article  PubMed  Google Scholar 

  9. Sonu S, Post S, Feinglass J. Adverse childhood experiences and the onset of chronic disease in young adulthood. Prev Med. 2019;123:163–70.

    Article  PubMed  Google Scholar 

  10. Bellis MA, Hughes K, Ford K, Ramos Rodriguez G, Sethi D, Passmore J. Life course health consequences and associated annual costs of adverse childhood experiences across Europe and North America: a systematic review and meta-analysis. Lancet Public Health. 2019;4:e517–28.

    Article  PubMed  PubMed Central  Google Scholar 

  11. Hofheimer JA, McGrath M, Musci R, Wu G, Polk S, Blackwell CK, et al. Assessment of psychosocial and neonatal risk factors for trajectories of behavioral dysregulation among young children from 18 to 72 months of age. JAMA Netw Open. 2023;6:e2310059–e2310059.

    Article  PubMed  PubMed Central  Google Scholar 

  12. Miller ES, Fleming O, Ekpe EE, Grobman WA, Heard-Garris N. Association between adverse childhood experiences and adverse pregnancy outcomes. Obstet Gynecol. 2021;138:770–6.

    Article  PubMed  PubMed Central  Google Scholar 

  13. Racine N, Devereaux C, Cooke JE, Eirich R, Zhu J, Madigan S. Adverse childhood experiences and maternal anxiety and depression: a meta-analysis. BMC Psychiatry. 2021;21:28.

    Article  PubMed  PubMed Central  Google Scholar 

  14. Racine N, Plamondon A, Madigan S, McDonald S, Tough S. Maternal adverse childhood experiences and infant development. Pediatrics. 2018;141:e20172495.

    Article  PubMed  Google Scholar 

  15. McDonald SW, Madigan S, Racine N, Benzies K, Tomfohr L, Tough S. Maternal adverse childhood experiences, mental health, and child behaviour at age 3: the all our families community cohort study. Prev Med. 2019;118:286–94.

    Article  CAS  PubMed  Google Scholar 

  16. Madigan S, Wade M, Plamondon A, Maguire JL, Jenkins JM. Maternal adverse childhood experience and infant health: biomedical and psychosocial risks as intermediary mechanisms. J Pediatr. 2017;187:282-289.e1.

    Article  PubMed  Google Scholar 

  17. Currie CL, Tough SC. Adverse childhood experiences are associated with illicit drug use among pregnant women with middle to high socioeconomic status: findings from the All Our Families Cohort. BMC Pregnancy Childbirth. 2021;21:133.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  18. Nwanaji-Enwerem JC, Van Der Laan L, Kogut K, Eskenazi B, Holland N, Deardorff J, et al. Maternal adverse childhood experiences before pregnancy are associated with epigenetic aging changes in their children. Aging. 2021;13:25653–69.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  19. Esteves KC, Jones CW, Wade M, Callerame K, Smith AK, Theall KP, et al. Adverse childhood experiences: implications for offspring telomere length and psychopathology. Am J Psychiatry. 2020;177:47–57.

    Article  PubMed  Google Scholar 

  20. Jawaid A, Roszkowski M, Mansuy IM. Chapter Twelve—Transgenerational Epigenetics of Traumatic Stress. In: Rutten BPF, editor. Prog Mol Biol Transl Sci [Internet]. Academic Press; 2018. p. 273–98. Available from: https://www.sciencedirect.com/science/article/pii/S187711731830053X

  21. Saavedra-Rodríguez L, Feig LA. Chronic social instability induces anxiety and defective social interactions across generations. Struct Funct Act Stress Anxiety. 2013;73:44–53.

    Google Scholar 

  22. Gapp K, Jawaid A, Sarkies P, Bohacek J, Pelczar P, Prados J, et al. Implication of sperm RNAs in transgenerational inheritance of the effects of early trauma in mice. Nat Neurosci. 2014;17:667–9.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  23. Lacal I, Ventura R. Epigenetic inheritance: concepts, mechanisms and perspectives. Front Mol Neurosci [Internet]. 2018;11. Available from: https://www.frontiersin.org/article/10.3389/fnmol.2018.00292

  24. Polinski KJ, Putnick DL, Robinson SL, Schliep KC, Silver RM, Guan W, et al. Periconception and prenatal exposure to maternal perceived stress and cord blood DNA methylation. Epigenet Insights. 2022;15:25168657221082044.

    Google Scholar 

  25. Brunst KJ, Tignor N, Just A, Liu Z, Lin X, Hacker MR, et al. Cumulative lifetime maternal stress and epigenome-wide placental DNA methylation in the PRISM cohort. Epigenetics. 2018;13:665–81.

    Article  PubMed  PubMed Central  Google Scholar 

  26. Kotsakis Ruehlmann A, Sammallahti S, Cortés Hidalgo AP, Bakulski KM, Binder EB, Campbell ML, et al. Epigenome-wide meta-analysis of prenatal maternal stressful life events and newborn DNA methylation. Mol Psychiatry. 2023;

  27. Houtepen LC, Hardy R, Maddock J, Kuh D, Anderson EL, Relton CL, et al. Childhood adversity and DNA methylation in two population-based cohorts. Transl Psychiatry. 2018;8:266.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  28. Scorza P, Duarte CS, Lee S, Wu H, Posner J, Baccarelli A, et al. Epigenetic intergenerational transmission: mothers’ adverse childhood experiences and DNA methylation. J Am Acad Child Adolesc Psychiatry. 2023;S0890–8567(23):00313–21.

    Google Scholar 

  29. Moore SR, Merrill SM, Sekhon B, MacIsaac JL, Kobor MS, Giesbrecht GF, et al. Infant DNA methylation: an early indicator of intergenerational trauma? Early Hum Dev. 2022;164:105519.

    Article  CAS  PubMed  Google Scholar 

  30. Folger AT, Nidey N, Ding L, Ji H, Yolton K, Ammerman RT, et al. Association between maternal adverse childhood experiences and neonatal SCG5 DNA methylation-effect modification by prenatal home visiting. Am J Epidemiol. 2022;191:636–45.

    Article  PubMed  Google Scholar 

  31. Grasso DJ, Drury S, Briggs-Gowan M, Johnson A, Ford J, Lapidus G, et al. Adverse childhood experiences, posttraumatic stress, and FKBP5 methylation patterns in postpartum women and their newborn infants. Psychoneuroendocrinology. 2020;114:104604.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  32. Eskenazi B, Bradman A, Gladstone EA, Jaramillo S, Birch K, Holland N. CHAMACOS, a longitudinal birth cohort study: lessons from the fields. J Child Health. 2003;1:3–27.

    Article  Google Scholar 

  33. Felitti VJ, Anda RF, Nordenberg D, Williamson DF, Spitz AM, Edwards V, et al. Relationship of childhood abuse and household dysfunction to many of the leading causes of death in adults. The Adverse Childhood Experiences (ACE) Study. Am J Prev Med. 1998;14:245–58.

    Article  CAS  PubMed  Google Scholar 

  34. Storey JD, Tibshirani R. Statistical significance for genomewide studies. Proc Natl Acad Sci. 2003;100:9440.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  35. Battram B, Yousefi P, Crawford G, Prince C, Babaei MS, Sharp G, et al. The EWAS Catalog: a database of epigenome-wide association studies [version 2; peer review: 2 approved]. Wellcome Open Res. 2022;7:41.

    Article  PubMed  PubMed Central  Google Scholar 

  36. Spiers H, Hannon E, Schalkwyk LC, Smith R, Wong CCY, O’Donovan MC, et al. Methylomic trajectories across human fetal brain development. Genome Res. 2015;25:338–52.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  37. Mulder RH, Neumann A, Cecil CAM, Walton E, Houtepen LC, Simpkin AJ, et al. Epigenome-wide change and variation in DNA methylation in childhood: trajectories from birth to late adolescence. Hum Mol Genet. 2021;30:119–34.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  38. Pedersen BS, Schwartz DA, Yang IV, Kechris KJ. Comb-p: software for combining, analyzing, grouping and correcting spatially correlated p values. Bioinformatics. 2012;28:2986–8.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  39. Langfelder P, Horvath S. WGCNA: an R package for weighted correlation network analysis. BMC Bioinf. 2008;9:559.

    Article  Google Scholar 

  40. Kanehisa M, Goto S. KEGG: Kyoto encyclopedia of genes and genomes. Nucleic Acids Res. 2000;28:27–30.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  41. Ashburner M, Ball CA, Blake JA, Botstein D, Butler H, Cherry JM, et al. Gene Ontology: tool for the unification of biology. Gene Ontol Consort Nat Genet. 2000;25:25–9.

    Article  CAS  Google Scholar 

  42. Gene Ontology Consortium. The Gene Ontology resource: enriching a GOld mine. Nucleic Acids Res. 2021;49:D325–34.

    Article  Google Scholar 

  43. Been JV, Kramer BW, Zimmermann LJI. In utero and early-life conditions and adult health and disease. N Engl J Med. 2008;359:1523–4.

    Article  CAS  PubMed  Google Scholar 

  44. Merrill SM, Moore SR, Gladish N, Giesbrecht GF, Dewey D, Konwar C, et al. Paternal adverse childhood experiences: associations with infant DNA methylation. Dev Psychobiol. 2021;63:e22174.

    Article  CAS  PubMed  Google Scholar 

  45. Van den Bergh BRH, Van Calster B, Smits T, Van Huffel S, Lagae L. Antenatal maternal anxiety is related to HPA-axis dysregulation and self-reported depressive symptoms in adolescence: a prospective study on the fetal origins of depressed mood. Neuropsychopharm Off Publ Am Coll Neuropsychopharm. 2008;33:536–45.

    Article  Google Scholar 

  46. Alhassen S, Chen S, Alhassen L, Phan A, Khoudari M, De Silva A, et al. Intergenerational trauma transmission is associated with brain metabotranscriptome remodeling and mitochondrial dysfunction. Commun Biol. 2021;4:783.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  47. Plecko B, Mills P. PNPO deficiency. GeneReviews. 2023.

  48. Rodan LH, Spillmann RC, Kurata HT, Lamothe SM, Maghera J, Jamra RA, et al. Phenotypic expansion of CACNA1C-associated disorders to include isolated neurological manifestations. Genet Med Off J Am Coll Med Genet. 2021;23:1922–32.

    CAS  Google Scholar 

  49. Li J, Zhao L, You Y, Lu T, Jia M, Yu H, et al. Schizophrenia related variants in CACNA1C also confer risk of autism. PLoS ONE. 2015;10:e0133247.

    Article  PubMed  PubMed Central  Google Scholar 

  50. Lu AT-H, Dai X, Martinez-Agosto JA, Cantor RM. Support for calcium channel gene defects in autism spectrum disorders. Mol Autism. 2012;3:18.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  51. Sklar P, Smoller JW, Fan J, Ferreira MAR, Perlis RH, Chambert K, et al. Whole-genome association study of bipolar disorder. Mol Psychiatry. 2008;13:558–69.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  52. Starnawska A, Demontis D, Pen A, Hedemand A, Nielsen AL, Staunstrup NH, et al. CACNA1C hypermethylation is associated with bipolar disorder. Transl Psychiatry. 2016;6:e831.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  53. Bastos CR, Tovo-Rodrigues L, Ardais AP, Xavier J, Salerno PSV, Camerini L, et al. The role of CACNA1C gene and childhood trauma interaction on bipolar disorder. Prog Neuropsychopharmacol Biol Psychiatry. 2020;101:109915.

    Article  CAS  PubMed  Google Scholar 

  54. Toth AB, Shum AK, Prakriya M. Regulation of neurogenesis by calcium signaling. Cell Calcium. 2016;59:124–34.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  55. Chen MA, LeRoy AS, Majd M, Chen JY, Brown RL, Christian LM, et al. Immune and epigenetic pathways linking childhood adversity and health across the lifespan. Front Psychol. 2021;12:788351.

    Article  PubMed  PubMed Central  Google Scholar 

  56. Elwenspoek MMC, Kuehn A, Muller CP, Turner JD. The effects of early life adversity on the immune system. Psychoneuroendocrinology. 2017;82:140–54.

    Article  CAS  PubMed  Google Scholar 

  57. Snijders C, Maihofer AX, Ratanatharathorn A, Baker DG, Boks MP, Geuze E, et al. Longitudinal epigenome-wide association studies of three male military cohorts reveal multiple CpG sites associated with post-traumatic stress disorder. Clin Epigenet. 2020;12:11.

    Article  Google Scholar 

  58. Katrinli S, Zheng Y, Gautam A, Hammamieh R, Yang R, Venkateswaran S, et al. PTSD is associated with increased DNA methylation across regions of HLA-DPB1 and SPATC1L. Brain Behav Immun. 2021;91:429–36.

    Article  CAS  PubMed  Google Scholar 

  59. Wade RJ, Becker BD, Bevans KB, Ford DC, Forrest CB. Development and evaluation of a short adverse childhood experiences measure. Am J Prev Med. 2017;52:163–72.

    Article  PubMed  Google Scholar 

  60. Hardt J, Rutter M. Validity of adult retrospective reports of adverse childhood experiences: review of the evidence. J Child Psychol Psychiatry. 2004;45:260–73.

    Article  PubMed  Google Scholar 

  61. Mallik S, Odom GJ, Gao Z, Gomez L, Chen X, Wang L. An evaluation of supervised methods for identifying differentially methylated regions in Illumina methylation arrays. Brief Bioinform. 2018;20:2224–35.

    Article  PubMed Central  Google Scholar 

  62. Lent S, Cardenas A, Rifas-Shiman SL, Perron P, Bouchard L, Liu C-T, et al. Detecting differentially methylated regions with multiple distinct associations. Epigenomics. 2021;13:451–64.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  63. Glover V, Hill J. Sex differences in the programming effects of prenatal stress on psychopathology and stress responses: an evolutionary perspective. Physiol Behav. 2012;106:736–40.

    Article  CAS  PubMed  Google Scholar 

  64. Duffy KA, Sammel MD, Johnson RL, Kim DR, Wang EY, Ewing G, et al. Maternal adverse childhood experiences impact fetal adrenal volume in a sex-specific manner. Biol Sex Differ. 2023;14:7.

    Article  PubMed  PubMed Central  Google Scholar 

  65. Merid SK, Novoloaca A, Sharp GC, Küpers LK, Kho AT, Roy R, et al. Epigenome-wide meta-analysis of blood DNA methylation in newborns and children identifies numerous loci related to gestational age. Genome Med. 2020;12:25.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  66. Solomon O, Huen K, Yousefi P, Küpers LK, González JR, Suderman M, et al. Meta-analysis of epigenome-wide association studies in newborns and children show widespread sex differences in blood DNA methylation. Mutat Res Mutat Res. 2022;789:108415.

    Article  CAS  Google Scholar 

  67. Bozack AK, Colicino E, Just AC, Wright RO, Baccarelli AA, Wright RJ, et al. Associations between infant sex and DNA methylation across umbilical cord blood, artery, and placenta samples. Epigenetics. 2022;17:1080–97.

    Article  PubMed  Google Scholar 

  68. Martin CL, Jima D, Sharp GC, McCullough LE, Park SS, Gowdy KM, et al. Maternal pre-pregnancy obesity, offspring cord blood DNA methylation, and offspring cardiometabolic health in early childhood: an epigenome-wide association study. Epigenetics. 2019;14:325–40.

    Article  PubMed  PubMed Central  Google Scholar 

  69. Markunas CA, Wilcox AJ, Xu Z, Joubert BR, Harlid S, Panduri V, et al. Maternal age at delivery is associated with an epigenetic signature in both newborns and adults. PLoS ONE. 2016;11:e0156361.

    Article  PubMed  PubMed Central  Google Scholar 

  70. Joubert BR, Felix JF, Yousefi P, Bakulski KM, Ligthart S, Wang T, et al. DNA methylation in newborns and maternal smoking in pregnancy: genome-wide consortium meta-analysis. Am J Hum Genet. 2016;98:680–96.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  71. Alfano R, Guida F, Galobardes B, Chadeau-Hyam M, Delpierre C, Ghantous A, et al. Socioeconomic position during pregnancy and DNA methylation signatures at three stages across early life: epigenome-wide association studies in the ALSPAC birth cohort. Int J Epidemiol. 2019;48:30–44.

    Article  PubMed  Google Scholar 

  72. Laubach ZM, Perng W, Cardenas A, Rifas-Shiman SL, Oken E, DeMeo D, et al. Socioeconomic status and DNA methylation from birth through mid-childhood: a prospective study in Project Viva. Epigenomics. 2019;11:1413–27.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  73. Bakulski KM, Feinberg JI, Andrews SV, Yang J, Brown S, McKenney L, S, et al. DNA methylation of cord blood cell types: applications for mixed cell birth studies. Epigenetics. 2016;11:354–62.

    Article  PubMed  PubMed Central  Google Scholar 

  74. Yousefi P, Huen K, Davé V, Barcellos L, Eskenazi B, Holland N. Sex differences in DNA methylation assessed by 450 K BeadChip in newborns. BMC Genom. 2015;16:911.

    Article  Google Scholar 

  75. Hanetz-Gamliel K, Dollberg DG. Links between mothers’ ACEs, their psychopathology and parenting, and their children’s behavior problems-A mediation model. Front Psychiatry. 2022;13:1064915.

    Article  PubMed  PubMed Central  Google Scholar 

  76. Shih EW, Ahmad SI, Bush NR, Roubinov D, Tylavsky F, Graff C, et al. A path model examination: maternal anxiety and parenting mediate the association between maternal adverse childhood experiences and children’s internalizing behaviors. Psychol Med. 2023;53:112–22.

    Article  PubMed  Google Scholar 

  77. Russotti J, Warmingham JM, Handley ED, Rogosch FA, Cicchetti D. Child maltreatment: an intergenerational cascades model of risk processes potentiating child psychopathology. Child Abuse Negl. 2021;112:104829.

    Article  PubMed  Google Scholar 

  78. Plant DT, Pawlby S, Pariante CM, Jones FW. When one childhood meets another - maternal childhood trauma and offspring child psychopathology: a systematic review. Clin Child Psychol Psychiatry. 2018;23:483–500.

    Article  PubMed  Google Scholar 

  79. Parade SH, Huffhines L, Daniels TE, Stroud LR, Nugent NR, Tyrka AR. A systematic review of childhood maltreatment and DNA methylation: candidate gene and epigenome-wide approaches. Transl Psychiatry. 2021;11:134.

    Article  PubMed  PubMed Central  Google Scholar 

  80. O’Donnell KJ, Chen L, MacIsaac JL, McEwen LM, Nguyen T, Beckmann K, et al. DNA methylome variation in a perinatal nurse-visitation program that reduces child maltreatment: a 27-year follow-up. Transl Psychiatry. 2018;8:15.

    Article  PubMed  PubMed Central  Google Scholar 

  81. Holand N, Furlong C, Bastaki M, Richter R, Bradman A, Huen K, et al. Paraoxonase polymorphisms, haplotypes, and enzyme activity in Latino mothers and newborns. Environ Health Perspect. 2006;114:985–91.

    Article  Google Scholar 

  82. Sandoval J, Heyn H, Moran S, Serra-Musach J, Pujana MA, Bibikova M, et al. Validation of a DNA methylation microarray for 450,000 CpG sites in the human genome. Epigenetics. 2011;6:692–702.

    Article  CAS  PubMed  Google Scholar 

  83. Fortin J-P, Labbe A, Lemire M, Zanke BW, Hudson TJ, Fertig EJ, et al. Functional normalization of 450k methylation array data improves replication in large cancer studies. Genome Biol. 2014;15:503.

    Article  PubMed  PubMed Central  Google Scholar 

  84. Aryee M, Jaffe A, Corrada-Bravo H, Ladd-Acosta C, Feinberg A, Hansen K, et al. Minfi: a flexible and comprehensive Bioconductor package for the analysis of Infinium DNA methylation microarrays. Bioinformatics. 2014;30:1363–9.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  85. Niu L, Xu Z, Taylor JA. RCP: A novel probe design bias correction method for Illumina Methylation BeadChip. Bioinformatics. 2016;32:2659–63.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  86. Johnson WE, Li C, Rabinovic A. Adjusting batch effects in microarray expression data using empirical Bayes methods. Biostat Oxf Engl. 2007;8:118–27.

    Google Scholar 

  87. Leek JT, Johnson WE, Parker HS, Jaffe AE, Storey JD. The sva package for removing batch effects and other unwanted variation in high-throughput experiments. Bioinformatics. 2012;28:882–3.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  88. Teschendorff AE, Breeze CE, Zheng SC, Beck S. A comparison of reference-based algorithms for correcting cell-type heterogeneity in Epigenome-Wide Association Studies. BMC Bioinf. 2017;18:105.

    Article  Google Scholar 

  89. Smyth GK. Linear models and empirical Bayes methods for assessing differential expression in microarray experiments. Stat Appl Genet Mol Biol. 2004. https://doi.org/10.2202/1544-6115.1027.

    Article  PubMed  Google Scholar 

  90. Du P, Zhang X, Huang C-C, Jafari N, Kibbe WA, Hou L, et al. Comparison of Beta-value and M-value methods for quantifying methylation levels by microarray analysis. BMC Bioinf. 2010;11:587.

    Article  CAS  Google Scholar 

  91. Xu Z, Niu L, Li L, Taylor JA. ENmix: a novel background correction method for Illumina HumanMethylation450 BeadChip. Nucl Acids Res. 2016;44:e20.

    Article  PubMed  Google Scholar 

  92. Langfelder P, Horvath S. Eigengene networks for studying the relationships between co-expression modules. BMC Syst Biol. 2007;1:54.

    Article  PubMed  PubMed Central  Google Scholar 

  93. Langfelder P, Zhang B, Horvath S. Defining clusters from a hierarchical cluster tree: the dynamic tree cut package for R. Bioinformatics. 2008;24:719–20.

    Article  CAS  PubMed  Google Scholar 

  94. Brinster R, Köttgen A, Tayo BO, Schumacher M, Sekula P, on behalf of the CKDGen Consortium. Control procedures and estimators of the false discovery rate and their application in low-dimensional settings: an empirical investigation. BMC Bioinf. 2018;19:78.

    Article  Google Scholar 

  95. Benjamini Y, Hochberg Y. Controlling the false discovery rate: a practical and powerful approach to multiple testing. J R Stat Soc. 1995;57:289–300.

    Google Scholar 

  96. Strimmer K. A unified approach to false discovery rate estimation. BMC Bioinf. 2008;9:303.

    Article  Google Scholar 

  97. Geeleher P, Hartnett L, Egan LJ, Golden A, Raja Ali RA, Seoighe C. Gene-set analysis is severely biased when applied to genome-wide methylation data. Bioinformatics. 2013;29:1851–7.

    Article  CAS  PubMed  Google Scholar 

  98. Young MD, Wakefield MJ, Smyth GK, Oshlack A. Gene ontology analysis for RNA-seq: accounting for selection bias. Genome Biol. 2010;11:R14.

    Article  PubMed  PubMed Central  Google Scholar 

Download references

Acknowledgements

We gratefully acknowledge CHAMACOS participants and staff.

Funding

This work was supported by the National Institutes of Health (R01ES026994; P01ES009605; R24ES028529, R01MD016595, and U24ES028529) and by the Environmental Protection Agency (R82670901).

Author information

Authors and Affiliations

Authors

Contributions

PC developed the data analysis plan, analyzed and visualized the data, and drafted the manuscript; AKB drafted the manuscript; SV drafted the manuscript; JCN reviewed and edited the manuscript; LVDL developed the data analysis plan and reviewed and edited the manuscript; KK was involved in data collection and management and reviewed and edited the manuscript; CR was involved in funding for the data acquisition and reviewed and edited the manuscript; BE was involved in developing the study methodology and funding for the data acquisition, and reviewed and edited the manuscript; NH was involved in developing the study methodology and funding acquisition and reviewed and edited the manuscript; JD was involved in developing the study methodology and funding acquisition and reviewed and edited the manuscript; AC conceptualized the project, developed the data analysis plan, was involved in funding acquisition, and reviewed and edited the manuscript.

Corresponding author

Correspondence to Andres Cardenas.

Ethics declarations

Ethics approval and consent to participate

Written informed consent was obtained from mothers. Child written consent was obtained at the 18-year visit. Study activities were approved by the University of California, Berkeley Committee for the Protection of Human Subjects.

Consent for publication

Not applicable.

Competing interests

The authors declare they have no competing interests.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Supplementary Information

Additional file 1: Table S1

. Participant characteristics of mother/newborn pairs with cord blood DNA methylation data (N = 372). Table S2. Weighted correlation analysis (WGCNA) module eigengene representativeness statistics. Table S3. Weighted correlation analysis (WGCNA) module eigengenes (MEs) associated with ACE exposures and pathway summaries. Fig. S1. Flowchart of selection process for mother/newborn pairs included in analyses. Fig. S2. Heatmap of pairwise odds ratios between maternal adverse childhood experiences (ACEs). Fig. S3. Manhattan plot for associations with the total number of maternal adverse childhood experiences (ACEs) modeled linearly. Fig. S4. Manhattan plots for associations with the total number of maternal adverse childhood experiences (ACEs) categorized as 0, 1–3, or 4–10. Fig. S5. Manhattan plots for associations with individual maternal adverse childhood experiences (ACEs) in a mutually adjusted model. Fig. S6. Q–Q plot for associations with the total number of maternal adverse childhood experiences (ACEs) modeled linearly. Fig. S7. Q–Q plots for associations with the total number of maternal adverse childhood experiences (ACEs) categorized as 0, 1–3, or 4–10. Fig. S8. Q–Q plots for associations with individual maternal adverse childhood experiences (ACEs) in a mutually adjusted model. Fig. S9. Correlations of module eigengenes (MEs) with individual maternal adverse childhood experience (ACE) indicators, total number of maternal ACEs, and covariates.

Additional file 2: Table S1

. Lookup of Moore et al. results including top CpG located in each correlated methylated region (p < 0.005) and individual CpGs (p < 0.0005), and EWAS results from the current study. Table S2. Lookup of Kotsakis Ruehlmann et al. results including CpGs associated with prenatal cumulative stress or individual stress domains in PACE (p value  <  2.4  ×  10−7), and EWAS results from the current study.

Additional file 3: Table S1.

Kyoto Encyclopedia of Genes and Genomes (KEGG) pathways enriched for modules associated with ACE exposures (FDR < 0.05). Table S2. Gene Ontology (GO) pathways enriched for modules associated with ACE exposures (FDR < 0.05).

Rights and permissions

Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Collender, P., Bozack, A.K., Veazie, S. et al. Maternal adverse childhood experiences (ACEs) and DNA methylation of newborns in cord blood. Clin Epigenet 15, 162 (2023). https://doi.org/10.1186/s13148-023-01581-y

Download citation

  • Received:

  • Accepted:

  • Published:

  • DOI: https://doi.org/10.1186/s13148-023-01581-y

Keywords